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ABSTRACT: The acquired resistance requires a genetic change; either mutations or the 
acquisition by horizontal gene transfer. However, there are situations in which resistance is not 
driven by a genetic change and bacteria become transiently resistant to antibiotics. The transient 
and reversible resistance can be achieved by different mechanisms, such as the formation of 
biofilms or persistent cells, which are related to the physiological state of the bacteria when it is 
exposed to a stressful condition. Persistent cells represent a fraction in a bacterial population that 
begins a dormancy phase under adverse conditions. Unlike bacteria that resist antibiotics by genetic 
mechanisms, persistent cells are unable to grow in the presence of an antibiotic. Pasteurella 
multocida and Streptococcus suis are important pathogens in the respiratory disorders of swine 
production. These bacteria produce frequents infections that could be considered recurrent. This 
work was aimed at detecting events of transitory resistance in vitro in both species. Four strains, 
susceptible to ß-lactamic and quinolone, corresponding to each species, were selected after 
previously confirming their susceptibility according to the classical testing method.  P. multocida 
strains were analyzed for surviving cells after exposure to 200 and 400 µgml-1 of Enrofloxacin and 
Ampicillin, respectively, while S. suis cells was treated with 100µgml-1of Penicillin and 200µgml-
1Enrofloxacin during 24 and 48 hours. S. suis and P. multocida strains formed persistent cells under 
the action of both antibiotics until a detectable concentration of 1x104 ufcml-1. The level of 
persistence varies among the strains. This is the first time that the formation of persistent cells by 
P. multocida has been described and corroborates this behavior previously described by other 
authors in S. suis strains. The potentiation assay showed that it is possible to eradicate persistent 
cells in vitro through the combinations of aminoglycoside (Gentamicin) with glycerol and 
Gentamicin with arginine The manifestation of these transient resistance phenotypes not associated 
to genetic changes can explain the therapeutic failures and recurrence in respiratory infections, 
which usually occur subclinically, reducing lung capacity and decreasing gain in weight.  
Key words: transient resistance, persistent cell, antibiotic tolerance, Pasteurella multocida, 
Streptococcus suis. 
RESUMEN: La resistencia adquirida requiere de cambios genéticos por mutaciones o la 
adquisición de genes por transferencia horizontal. Sin embargo, existen situaciones en las cuales la 
resistencia no es producto de cambios genéticos y las bacterias se manifiestan resistentes 
transitoriamente. La resistencia reversible y transitoria se logra por diferentes mecanismos, como 
formación de biopelículas o las células persistentes, las cuales se relacionan con el estado 
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fisiológico de la bacteria cuando se expone a una condición estresante. Las células persistentes 
representan una fracción en una población bacteriana que, bajo condiciones adversas, comienza 
una fase de dormancia. A diferencia de las bacterias que resisten a los antibióticos por mecanismos 
genéticos, las células persistentes son incapaces de crecer en presencia de un antibiótico. La 
resistencia que se caracteriza por la supervivencia de una fracción de la población bacteriana, en 
presencia de un antibiótico, pero sin crecimiento, se define como resistencia transitoria y juega un 
papel importante en la recurrencia de infecciones. Pasteurella multocida y Streptococcus suis son 
patógenos importantes en los trastornos respiratorios de la producción porcina; estas bacterias 
producen frecuentes infecciones que pueden ser consideradas recurrentes. El presente trabajo tuvo 
como objetivo detectar eventos de resistencia transitoria in vitro en ambas especies. Se 
seleccionaron cuatro cepas correspondientes a cada especie después de confirmar previamente su 
susceptibilidad en el ensayo de difusión en agar con disco a dos fármacos utilizados para controlar 
ambas infecciones (ß-lactámicos y fluoroquinolona). Las cepas de P. multocida se analizaron en 
busca de células supervivientes después de la exposición a 200 y 400 μgml-1 de Enrofloxacina y 
Ampicilina, respectivamente, mientras S. suis se trató con 100 μgml-1 de Penicilina y 200 μgml-1 
de Enrofloxacina durante 24 y 48 horas. Las cepas de S. suis y P. multocida formaron células 
persistentes bajo la acción de ambos antibióticos hasta una concentración detectable equivalente a 
1x104 ufcml-1. El nivel de persistencia varió entre estas cepas. Esta es la primera vez que se describe 
la formación de células persistentes por P. multocida y corrobora este comportamiento previamente 
descrito por otros autores en cepas de S. suis. El ensayo de potenciación mostró que es posible la 
erradicación de células persistentes in vitro a través de las combinaciones de aminoglucósido 
(Gentamicina) con glicerol y Gentamicina con arginina.  La manifestación de estos fenotipos de 
resistencia transitoria no asociados a cambios genéticos puede explicar fracasos terapéuticos y 
recurrencia en las infecciones respiratorias, que habitualmente ocurren subclínicamente, reducen  
la capacidad pulmonar y disminuyen la ganancia en el peso. 
Palabras clave: resistencia transitoria, célula persistente, tolerancia antibiótico, Pasteurella 
multocida, Streptococcus suis. 
INTRODUCTION 
Actually the ability of microorganisms to 
resist antibiotics is one of the most important 
challenges in human and veterinary health. The 
consequences of the antimicrobial resistance 
are the impossibility of treating infections 
correctly, prolonged illnesses, deaths, 
production losses and negative consequences 
for food security (1,2). 
The acquired resistance to antibiotics is the 
result of insertions, deletions and mutations in 
the existing genes or the acquisition of external 
resistance encoding elements like plasmid and 
tramposones. The major research approach has 
been directed to the acquired resistance (2). But 
unfortunately, the bacteria lacking of resistance 
genes and susceptible to antibiotics in the 
laboratory test such as Agar disc diffusion 
could reveal an unexpected behavior, which 
was described as “transient resistance” or 
“tolerance antibiotic” without the acquisition of 
a genetic change. The formation of biofilms or 
persistent cells are expressions of this transient 
resistance (2,3).  
The biofilms are microbial communities that 
can be formed within soft tissues or surfaces 
where the bacteria are protected from the 
immune system or antibiotics by a layer of 
exopolymers (2,3,4). Persistent cells represent a 
small subpopulation of cells that spontaneously 
enter a dormant, non dividing state, therefore 
becoming highly tolerant to kill with lethal 
doses of bactericidal antibiotics, reaching this 
state without undergoing the genetic change 
(5).Therefore, the antibiotics  depend on the 
physiological activity of the bacterial cells, 
interfering with the active cellular processes, 
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such as macromolecular synthesis, lack of 
effectiveness on persistent cells, which are 
dormant or their metabolic activity  is reduced. 
Such cells could revert to a growing state after 
antibiotic treatment is ceased. Both expressions 
(biofilms and persistent cells) play an important 
role in the recalcitrance of infections (5,6). 
Some bacteria that colonize the respiratory 
tract produce recurrent infections, probably due 
to expressions of transient resistance such as 
biofilms or persistent cells (2,3,5,6). 
Respiratory infections are one of the most 
important health problems in pig herds, due to 
the multifactorial nature. S. suis and P. 
multocida species are important pathogens, 
involved in causing great economic losses to 
the swine industry (7,8). S. suis is also regarded 
as an important zoonotic agent with a 
significant increase of infectious in humans 
(7,9). The tolerance to antibiotics by the 
formation of persistent cells could be a possible 
explanation for therapeutic failures and 
recurrent infections by these pathogens (9,10).  
Researches about persistent cells have been 
focused on knowing the mechanisms that 
support this behavior, as well as the strategies 
for their eradication. In this sense, combinations 
of drugs have been used. The aminoglycoside 
(AG) activity can be potentiated by stimulating 
proton motive force generation in persistent 
cells through carbonate metabolites. This effect 
is known as potentiation (10,11). 
The formation of persistent cells was 
reported for S. suis, (12), but not yet for P. 
multocida. While the effect of carbon  
 
 
 
 
 
 
 
 
 
 
 
 
metabolites combined with AG in vitro for the 
eradication of S. suis and P. multocida 
persistent cells has not been described yet. This 
work was aimed at detecting the transient 
resistance events specifically the production of 
persistent cells in S. suis and P. multocida 
strains from pigs in Cuba, and to evaluate the 
effect of carbonate metabolites in combination 
with AG for the eradication of persistent cells 
in vitro. 
MATERIALS AND METHODS 
Strains and culture conditions 
The bacterial strains used in this study are 
part of the collection of the Animal 
Bacteriology Laboratory of the National Center 
for Animal and Plant Health (CENSA), isolated 
from pig with pneumonia. All S. suis and P. 
multocida strains were identified and serotyped 
as previously described (13,14,15). The 
bacterial stock was stored in glycerol (20%) at 
-20°C, and all strains were cultured on 
Columbia (BIOCEN) agar plates containing 5% 
sterile ovine blood at 37oC for 24 hours. 
Eight strains were selected from the 
collection, four corresponding to each species. 
These strains were classified as susceptible 
according classical testing methods for two 
drugs (ß-lactamic and fluorquinolone), usually  
used to control both infections (Table 1) 
according to previous results (14,16). The 
cultures of each P. multocida and S. suis strain 
were obtained in Brain Hearth broth (BHB) and 
Todd Hewit Broth (THB), respectively.  
 
 
 
 
 
 
 
 
TABLE 1. Strains used in this study./Cepas utilizadas en el studio. 
Identification Species Capsular serogroup 
PM21 Pasteurella multocida A 
PM5 Pasteurella multocida A 
PM29 Pasteurella multocida A 
PM8K Pasteurella multocida A 
Ss NT Streptococcus suis Non typeable 
SsS2 Streptococcus suis Serotype 2 
SsS3 Streptococcus suis Serotype 3 
SsS9 Streptococcus suis Serotype 9 
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Reagents 
The antibiotics used were Ampicillin, 
Enrofloxacin for P. multocida, Penicillin- 
Enrofloxacin for S. suis and Gentamicin for 
both bacteria. Stock solutions were prepared 
from each, following CLSI recommendations 
(17), sterilized with sterile 0.22 μm pore 
diameter filters. All aliquots were stored at -
20°C and protected from light. The carbon 
sources used (Arginine, Fructose, Glycerol, 
Glucose, Manytol, Rafinose, Starch, and 
Trealose) were purchased from Sigma-Aldrich. 
Minimal Inhibition Concentration (MIC) 
MIC was determined using the microdilution 
method (18). Briefly, an overnight culture was 
diluted in an inoculum of approximately 5.105 
CFUml-1 in Muller Hinton Broth (P. multocida) 
and Todd Hewith Broth (S. suis), and incubated 
with a 2-fold antibiotic concentration range 
(500-1 µgml-1) from 16 to 20 h. The optical 
density was measured at 595 nm using a 
microtiter plate reader (SUMA, PR-621, Cuba), 
and the lowest concentration of the antibiotic 
that did not exceed an OD of 0.01was taken to 
be the MIC of that antibiotic. 
Time and concentration-dependent killing 
experiments 
Stationary phase cultures of all S. suis and P. 
multocida strains were obtained. The 
concentration of viable cells was determined by 
counting the colony forming units (CFUs) on 
Columbia agar plates supplemented with 5% 
ovine blood (CBA). In all cases, 0.5 ml of the 
culture was transferred to microcentrifuge tube, 
antimicrobials were added at 100-fold MIC and 
cultures were incubated until 48 h. For CFU 
determinations, 100 μl samples were taken 
during the antimicrobial challenge after 24 and 
48 hours during long-term experiments. Cells 
were harvested by centrifugation and washed in 
1% NaCl solution. The number of persistent 
cells was determined by plaque counting. 
Colonies were counted after incubation for 48h 
at 37°C. All experiments were performed with 
two independent biological replicates (5). 
Heritability of persistence 
The stationary phase cultures (5ml) were 
exposed to 100-fold MIC of Penicillin (S. suis, 
strain SSNT) and 100-fold MIC Ampicillin (P. 
multocida strain PM5), for 5 h. Subsequently, 
cells were washed in 1% NaCl solution. 
Surviving cells were re-suspended into 5 ml 
fresh broth without antibiotics until the 
stationary phase was reached again. They were 
subjected to antimicrobial treatment as 
described and the procedure was carried out 
three consecutive cycles (19). 
Aminoglycoside potentiation assay 
The persistent population was isolated after 
18 h treatment (ß-lactamic) by centrifugation at 
5000 g for 5 min. Cells were washed with 
minimal medium (M9), centrifuged, and finally 
re-suspended in M9 medium without any 
carbon source. The persistent population was 
then treated with gentamicin 250µgml_1 and 
600mM following the carbon compounds: 
Arginine, Fructose, Glycerol, Glucose, 
Manytol, Rafinose, Starch, and Trealose. 
Controls with gentamicin without carbon 
source were included. Bacterial counts were 
carried out as previously described (20).The 
experiment was performed with three 
independent biological replicates. 
Statistical analysis 
Bacterial counts (CUF/ml) from each 
biological replicate were log10 transformed 
prior to statistical analysis using Microsoft 
Excel. Variance analysis and a comparison test 
of multiple Tukey ranges with a significance 
level of 0.05 were used to determine whether 
the number of surviving persistent cells was 
significantly different upon the different 
conditions with respect to the untreated control. 
All analyses were performed using the 
statistical package INfoStat 2016 (21). 
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RESULTS AND DISCUSSION 
Although, different authors have suggested 
that all bacteria species have the potential 
capacity to form persistent cells (6,22), specific 
studies on the behavior of the species and their 
strains should be carried out, because the 
molecular bases explaining cell persistence 
events in bacteria are not fully known. 
In this study, the eight strains tested were 
sensitive to ß-lactamic and quinolone 
antibiotics. The ranges of MIC values for 
Penicillin were 1 µgml-1- 0.5 µgml-1 and 
Enrofloxacin (2µgml-1-1µgml-1) for S. suis 
strains, while for P. multocida strains, the 
antibiotics exhibited these value ranges: 
Ampicillin (2µgml-1-1µgml-1) and 
Enrofloxacin (4µgml-1-2 µgml-1). For the 
subsequent killing curve experiments, MIC 
values were defined as follows for S. suis: 
Penicillin (1 µgm-1) and Enrofloxacin (2 µgml-
1). In this definition, the data found in this work, 
as well as the MIC values reported in other 
studies (23,24) for S. suis, were taken into 
account. The MIC values established for P. 
multocida were Ampicillin (2µgml-1) and 
Enrofloxacin (4µgml-1), which coincided with 
the criteria of the European Committee on 
Antimicrobial Susceptibility Testing 
(EUCAST) (25). 
For isolating drug-tolerant S. suis and P. 
multocida persisters, bactericidal antibiotics 
which act on the common bacterial target 
structures, such as the cell envelope (Ampicillin 
and Penicillin) or topoisomerase (Enrofloxacin) 
(26), were applied. CFU count of the liquid 
culture did not increase to a sizeable extent after 
the antibiotic challenge, and the strains of both 
pathogens exhibited a biphasic killing kinetics 
during the experiment. The cells, 
approximately (109CFUml-1) of S. suis, was 
killed until 107 CFUml-1, reaching a plateau or 
a slow decrease of surviving cells to 104 CFU 
ml-1 (Figure 1A-B), similar for P. multocida 
strains (Figure 2A-B). Biphasic killing curves 
are the experimental hallmark of persistence 
and are obtained when a lethal dose of a 
bactericidal antibiotic is added to a bacterial 
population and the number of surviving cells is 
followed over time (27,28). All S. suis and P. 
multocida strains revealed a range of tolerance 
cells for both antibiotics, although there was a 
slight differences. This is consistent with the 
results of some authors who have found that the 
persistence degree among strains was different 
(29,30,31).  
Two different types of persistent cells have 
been defined, type I persistent cells from 
stationary growth phase cultures, whereas type 
II persistent cells have their origin in 
exponential growth phase cultures (12,32,33). 
In this work, the bactericidal activity evaluated, 
using the concentration-killing curves and the 
antibiotic, were supplied to both P. multocida 
and S. suis cultures in the stationary phase. The 
logarithmic phase culture was not evaluated 
according to different previous studies on S. 
suis and other species where the number of the 
persistent cells observed was higher during the 
stationary growth when compared to the 
exponential grown bacteria (12,28).  
Previous studies have established persistent 
cells are tolerant to multiple antibiotics (5). 
However in this study, the strains PM21 and 
PM29 failed to produce a detectable level of 
such cells after 48 hours of challenge with 
Enrofloxacin. But when the strains were treated 
with ampicillin, PM29 was tolerant, while 
PM21 did not survive (Figure 2 A-B). This 
result is consistent with the studies of 
Hofsteenge et al., 2013 (30), who did not find a 
correlation between persistent levels for 
different antibiotics among environmental E. 
coli strains.  Barth et al., 2013 (31) neither 
found a correlation among the different 
antibiotics and the persistent cells from 
Acinetobacter baumannii clinical isolates. 
Most of the transient resistance researches 
have been focused on the following microbial 
groups (Escherichia coli, Mycobacterium 
tuberculosis, Pseudomona aeroginosa, 
Staphyloccus aureus), based on the use of 
strains that were genetically manipulated 
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FIGURE 1. Time-dependent killing of Streptococcus suis. Cultures in stationary phase of each of 
four S. suis strains (Ss serotype 2, Ss non-typeable, Ss serotype 3 and Ss serotype 9) were treated 
with A) Penicillin 100xMCI and B) Enrofloxacin 100xMCI. An identical culture of each strain 
without any antibiotic challenge served as a control. Experiments were performed with two 
biological replicates, respectively. Error bars indicate the standard deviations./ Curvas de letalidad 
de  Streptococcus suis. Cultivos en fase estacionaria de cada una de las cuatro cepas de S. suis (Ss 
serotipo 2, Ss no tipificable, Ss serotipo 3 y Ss serotipo 9) se trataron con A) Penicilina 100xMCI 
y B) Enrofloxacina 100xMCI. Un cultivo de cada cepa al cual no se le adicionó antibiótico se 
utilizó como control. Los experimentos se realizaron con dos réplicas biológicas, las barras de 
error indican la desviación estándar.  
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FIGURE 2. Time-dependent killing of Pasteurella multocida. Cultures in stationary phase of 
each of four P. multocida strains (PM5, PM21, PM29 and PM8K) were treated with A) 
Ampicillin 100xMCI and B) Enrofloxacin 100xMCI. An identical culture of each strain without 
any antibiotic challenge served as a control. Experiments were performed with two biological 
replicates, respectively. Error bars indicate the standard deviations./ Curvas de letalidad de  
Pasteurella multocida. Cultivos en fase estacionaria de cada una de las cuatro cepas de P. 
multocida (PM5, PM21, PM29 and PM8K) se trataron con A) Ampicillin 100xMCI y B) 
Enrofloxacina 100xMCI. Como control se utilizó un cultivo de cada cepa al que no se le 
adicionó antibiótico. Los experimentos se realizaron con dos réplicas biológicas, las barras de 
error indican la desviación estándar.  
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previously to favor an increase or decrease in 
the production of persistent cells (35,36). Some 
of these previous studies based on the use of 
mutant strains have demonstrated the relative 
and redundant nature of persistent cells 
(32,34,35). However the studies using 
collections of non-genetically manipulated 
strains are scarce. A study carried out in a 
collection of E. coli strains from environmental 
origin showed that there were differences in the 
amount of persistent cells derived from each 
strain, once they were confronted with 
antibiotics from different families (30). In these 
work, S. suis and P. multocida strains showed 
variations in the frequency of persistent cells.  
The heterogeneous behavior showing the 
strains as regard the persistent cell formation 
may have different explanations. First, the 
intrinsic properties to each strain (34). Second, 
and according to Luidalepp et al (35), the 
bacterial cultures genetically homogeneous can 
generate subpopulations with different 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
physiological properties. When stationary-
phase bacteria are diluted in fresh medium, 
some cells start growing immediately and some 
later. Therefore, inoculum age had effects on 
the frequency of persistent cell formation. In 
this study, even still when the cultures were 
previously adjusted to a similar concentration, 
the strains differed in the persistent range 
(36,37).  
In order to examine the possible heritability 
of phenotypic resistance, SsS3 and PM5 strains, 
which previously showed high persistence 
levels under the effect of both antibiotics 
(Penicillin and Ampicillin), were selected for 
the heritability assay.  The stationary phase 
cultures of these strains were treated with ß-
lactamics. The survival cells were inoculated in 
fresh medium, and a newly fraction of initial 
culture survived to the treatment. The same 
occurred for a third challenge with the 
antibiotic, showing a biphasic curve (Figure 3),  
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FIGURE 3. Time-dependent killing of S. suis (black circle) and P.multocida (white circle). 
Experiments were performed with two biological replicates and error bars indicated the standard 
deviations. Two persistent isolates (SsNT and PM5), which survived 24 h of treatment with 100 
µgml-1 of Penicillin and Ampicillin, respectively, were exposed to a three 24-h treatment with 
100 µgml-1./Curvas de muerte dependientes del tiempo de S.suis (círculos negros) y P.multocida 
(círculos blancos). Los experimentos se realizaron con dos réplicas biológicas y las barras 
indican la desviación estándar. Dos aislados persistentes (SsNT y PM5) que sobrevivieron a un 
tratamiento por 24 horas con 100 µgml-1 de Penicilina y Ampicilina, respectivamente, se 
expusieron a  tres tratamientos en similares condiciones.  
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indicating that the resistance phenotype was 
transient, not being the consequence of a 
genetic change. Each culture obtained from the 
persistent cells was as sensible to ß- lactamic as 
the parental culture. If the cells had been able to 
grow once the antibiotic was retired due a 
genetic resistance mechanism, then such 
behavior would have been different, the 
population would not have decreased and a 
biphasic curve would not have been obtained, 
because the bacterial population would have 
increased in each cycle. 
The mechanism of persistent cell formation 
is not well understood and the metabolic state 
of these cells is debated. The main model that 
explains the genetic basis of the formation of 
persistent cells consists of a toxin-antitoxin 
(TA) system, inducing a dormancy state 
(38,39,40), and allowing cells to survive to the 
effects of antibiotics. TA systems (41) 
generally consist of a stable toxin (protein) that 
disrupts an essential cellular process (e.g., 
translation via mRNA degradation) and a labile 
antitoxin (either RNA or a protein) that 
prevents toxicity (38,39). Other model is the 
alarmoneguanosinetetraphosphate (ppGpp) that 
also directly reduces DNA replication and 
protein synthesis (40,41). 
When a culture is treated with a bactericidal 
antibiotic in high doses, it is possible to find 
dead cells, viable but non-culturable cells 
(VBNCs) and persistent cells. There are current 
different techniques for the isolation and 
discrimination among these types of cells 
(42,43,44). In this work, normally growing 
strains of both S. suis and P. multocida were 
lysed with ß-lactamic (Penicillin and 
Ampicillin), respectively. The non-lysed live 
cells were sedimented by centrifugation and 
subjected to the aminoglycosides (AG) 
potentiation assay with the following carbon 
sources (Arginine, Fructose, Glycerol, Glucose, 
Mannitol, Rafinose, Starch, and Trealose). 
Figure 4 shows the effect of the combination of 
carbonate metabolites with AG (Gentamicine) 
on the persistent cells previously obtained for 
each of the strains of both pathogens. The 
persistent cells of both microorganisms treated 
with gentamicine and metabolite of carbon 
decreased with respect to the cultures only 
treated with gentamicine. Glycerol, arginine 
and starch were the carbonate metabolites that 
most strongly potentiated the AG activity in 
both Penicillin and Ampicillin persistent cells 
obtained from the stationary-phase cultures of 
S. suis and P. multocida (Figure 4). The 
addition of carbonate metabolites which served 
to generate a proton motive, forced to conduce 
to the incorporation of AG, therefore making 
the cells more susceptible to gentamicine (45). 
Numerous research have corroborated that 
persistent cells are metabolically inactive or 
predominantly dormant (46). Therefore the 
strategies to kill these sleeping cells require 
compounds that enter the cell without an active 
transport. Some examples include DNA-cross-
linking compounds as mitomicyn C or 
acyldepsipeptide, a protease that degrades 
many cellular proteins (44). Another alternative 
to eradicate these dormant cells consists   in 
waking them in order to use traditional 
compounds as antibiotics, specifically AG 
(Gentamicin, kanamycin and streptomycin) in 
combination with carbon metabolites 
(41,44,45).  
The results indicated that Glycerol was the 
metabolite that, in combination with AG 
gentamicine, completely eradicated the 
persistent cells produced by both S. suis and P. 
multocida strains after the treatment with ß-
lactamic (Figure 4). Mehmet et al (46) found 
that glycerol was the metabolite that, in 
conjunction with AG, decreased different 
metabolic types of E. coli persistent cells. The 
combination Arginine plus G also eradicated 
persistent cells. Arginine is a crucial amino acid 
that modulate the cellular immune response 
during infection in the host. The importance of 
arginine metabolism has been reported in many 
pathogens like Salmonella typhimurium, 
Helicobacter pylori, Mycobacterium 
tuberculosis, and Streptococcus suis, as a 
source of energy and as a trigger for the 
polyamine synthesis required 
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for an efficient pathogenesis (47,48). 
The persistence of bacteria that can produce 
recalcitrant infections requires attention. This 
study has been focused on testing the formation 
of persistent cells in S. suis and P. multocida 
strains. In the case S. suis, its ability to tolerate 
antibiotics through the formation of persistent 
cells had already been informed (12). Although 
it has been considered that all bacteria have this 
ability, to our knowledge, prior to this study the 
formation of persistent cells for P. multocida 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
had not been described. 
S. suis and P. multocida strains formed 
persistent cells, but varying intensities, this 
phenotype could be wide distributed among S. 
suis and P. multocida isolates. Persistence 
understanding may contribute to improve the 
strategies aiming at the control of recurrent 
infections. Persistent cells should be taken into 
account when S. suis or P. multocida infections 
are produced in pigs and are not solved with an  
antimicrobial treatment. 
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FIGURE 4. Aminoglycoside potentiating assay for persistent cells. Stationary-phase cultures 
were treated with ß-lactamic for 5 hours, and cells were incubated in M9 minimal medium with 
Gentamicin (G) and different carbon sources (Arginine, Fructose, Glycerol, Glucose, Manytol, 
Rafinose, Starch, and Trealose). For controls, G 100 µg/ml was used. The survival fraction was 
determined based on CFU. Error bars indicate the standard errors of the means./ Ensayo de 
potenciación con aminoglucósidos para células persistentes. Cultivos en fase estacionaria se 
trataron con antibiótico ß-lactámicos por 5 horas, las células se incubaron en el medio mínimo 
M9 con Gentamicina (G) y diferentes fuentes de carbono (Arginina, Fructosa, Glicerol, 
Glucosa, Manitol, Rafinosa, Almidón, Trealosa). Las células persistentes tratadas solamente 
con gentamicina (100 µg/ml) se utilizaron como control. La fracción de células sobrevivientes 
se determinó mediante conteo de UFC. Las barras indican la desviación estándar de las medias.  
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It has been postulated that persistence is an 
important contributor to resistance emergence 
because it produces a continuous reservoir of 
viable cells in the presence of antibiotics (19). 
These results broaden the evidences about 
pathogens in veterinary medicine producing 
persistent cells, corroborating the observations 
on the differences in persistent levels among 
species or even among strains of the same 
species. Finally, it has been demonstrated that 
glycerol and arginine potentiated the effect of 
AG gentamicine in the eradication of persistent 
cells. 
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